These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 8133267

  • 21. Neuronal nicotinic receptor beta2 and beta4 subunits confer large differences in agonist binding affinity.
    Parker MJ, Beck A, Luetje CW.
    Mol Pharmacol; 1998 Dec; 54(6):1132-9. PubMed ID: 9855644
    [Abstract] [Full Text] [Related]

  • 22. (+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors.
    Sullivan JP, Decker MW, Brioni JD, Donnelly-Roberts D, Anderson DJ, Bannon AW, Kang CH, Adams P, Piattoni-Kaplan M, Buckley MJ.
    J Pharmacol Exp Ther; 1994 Nov; 271(2):624-31. PubMed ID: 7965777
    [Abstract] [Full Text] [Related]

  • 23. Partial agonist properties of cytisine on neuronal nicotinic receptors containing the beta 2 subunit.
    Papke RL, Heinemann SF.
    Mol Pharmacol; 1994 Jan; 45(1):142-9. PubMed ID: 8302273
    [Abstract] [Full Text] [Related]

  • 24. Cytisine binds with similar affinity to nicotinic alpha4beta2 receptors on the cell surface and in homogenates.
    Zhang J, Steinbach JH.
    Brain Res; 2003 Jan 03; 959(1):98-102. PubMed ID: 12480162
    [Abstract] [Full Text] [Related]

  • 25. C3-halogenation of cytisine generates potent and efficacious nicotinic receptor agonists.
    Abin-Carriquiry JA, Voutilainen MH, Barik J, Cassels BK, Iturriaga-Vásquez P, Bermudez I, Durand C, Dajas F, Wonnacott S.
    Eur J Pharmacol; 2006 Apr 24; 536(1-2):1-11. PubMed ID: 16563372
    [Abstract] [Full Text] [Related]

  • 26. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
    Donnelly-Roberts DL, Puttfarcken PS, Kuntzweiler TA, Briggs CA, Anderson DJ, Campbell JE, Piattoni-Kaplan M, McKenna DG, Wasicak JT, Holladay MW, Williams M, Arneric SP.
    J Pharmacol Exp Ther; 1998 May 24; 285(2):777-86. PubMed ID: 9580626
    [Abstract] [Full Text] [Related]

  • 27. A high-affinity site for acetylcholine occurs close to the alpha-gamma subunit interface of Torpedo nicotinic acetylcholine receptor.
    Dunn SM, Conti-Tronconi BM, Raftery MA.
    Biochemistry; 1993 Aug 24; 32(33):8616-21. PubMed ID: 8357804
    [Abstract] [Full Text] [Related]

  • 28. Regulation of human alpha4beta2 neuronal nicotinic acetylcholine receptors by cholinergic channel ligands and second messenger pathways.
    Gopalakrishnan M, Molinari EJ, Sullivan JP.
    Mol Pharmacol; 1997 Sep 24; 52(3):524-34. PubMed ID: 9281615
    [Abstract] [Full Text] [Related]

  • 29. In vivo labeling of nicotinic cholinergic receptors in brain with [3H]cytisine.
    Flesher JE, Scheffel U, London ED, Frost JJ.
    Life Sci; 1994 Sep 24; 54(24):1883-90. PubMed ID: 8196506
    [Abstract] [Full Text] [Related]

  • 30. Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.
    Riganti L, Matteoni C, Di Angelantonio S, Nistri A, Gaimarri A, Sparatore F, Canu-Boido C, Clementi F, Gotti C.
    Br J Pharmacol; 2005 Dec 24; 146(8):1096-109. PubMed ID: 16273122
    [Abstract] [Full Text] [Related]

  • 31. Distribution and development of nicotinic acetylcholine receptor subtypes in the optic tectum of Rana pipiens.
    Butt CM, Pauly JR, Debski EA.
    J Comp Neurol; 2000 Aug 07; 423(4):603-18. PubMed ID: 10880991
    [Abstract] [Full Text] [Related]

  • 32. Ligand binding and activation of rat nicotinic alpha4beta2 receptors stably expressed in HEK293 cells.
    Sabey K, Paradiso K, Zhang J, Steinbach JH.
    Mol Pharmacol; 1999 Jan 07; 55(1):58-66. PubMed ID: 9882698
    [Abstract] [Full Text] [Related]

  • 33. Localization of [3H]nicotine, [3H]cytisine, [3H]epibatidine, and [125I]alpha-bungarotoxin binding sites in the brain of Macaca mulatta.
    Han ZY, Zoli M, Cardona A, Bourgeois JP, Changeux JP, Le Novère N.
    J Comp Neurol; 2003 Jun 16; 461(1):49-60. PubMed ID: 12722104
    [Abstract] [Full Text] [Related]

  • 34. Characterization of [3H]ABT-418: a novel cholinergic channel ligand.
    Anderson DJ, Williams M, Pauly JR, Raszkiewicz JL, Campbell JE, Rotert G, Surber B, Thomas SB, Wasicak J, Arneric SP.
    J Pharmacol Exp Ther; 1995 Jun 16; 273(3):1434-41. PubMed ID: 7791118
    [Abstract] [Full Text] [Related]

  • 35. Gene targeting demonstrates that alpha4 nicotinic acetylcholine receptor subunits contribute to expression of diverse [3H]epibatidine binding sites and components of biphasic 86Rb+ efflux with high and low sensitivity to stimulation by acetylcholine.
    Marks MJ, Meinerz NM, Drago J, Collins AC.
    Neuropharmacology; 2007 Sep 16; 53(3):390-405. PubMed ID: 17631923
    [Abstract] [Full Text] [Related]

  • 36. Synthesis, binding, and modeling studies of new cytisine derivatives, as ligands for neuronal nicotinic acetylcholine receptor subtypes.
    Tasso B, Canu Boido C, Terranova E, Gotti C, Riganti L, Clementi F, Artali R, Bombieri G, Meneghetti F, Sparatore F.
    J Med Chem; 2009 Jul 23; 52(14):4345-57. PubMed ID: 19548687
    [Abstract] [Full Text] [Related]

  • 37. Characterization of nicotinic acetylcholine receptors that modulate nicotine-evoked [3H]norepinephrine release from mouse hippocampal synaptosomes.
    Azam L, McIntosh JM.
    Mol Pharmacol; 2006 Sep 23; 70(3):967-76. PubMed ID: 16735605
    [Abstract] [Full Text] [Related]

  • 38. Effects of oxidizing and reducing analogs of acetylcholine on neuronal nicotinic receptors.
    Xie Y, Jones GS, Loring RH.
    Mol Pharmacol; 1992 Aug 23; 42(2):356-63. PubMed ID: 1301068
    [Abstract] [Full Text] [Related]

  • 39. alpha 4 beta 2 subunit combination specific pharmacology of neuronal nicotinic acetylcholine receptors in N1E-115 neuroblastoma cells.
    Zwart R, Abraham D, Oortgiesen M, Vijverberg HP.
    Brain Res; 1994 Aug 22; 654(2):312-8. PubMed ID: 7527290
    [Abstract] [Full Text] [Related]

  • 40. Characterization of a series of anabaseine-derived compounds reveals that the 3-(4)-dimethylaminocinnamylidine derivative is a selective agonist at neuronal nicotinic alpha 7/125I-alpha-bungarotoxin receptor subtypes.
    de Fiebre CM, Meyer EM, Henry JC, Muraskin SI, Kem WR, Papke RL.
    Mol Pharmacol; 1995 Jan 22; 47(1):164-71. PubMed ID: 7838125
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.